Top Drug Development Journals

Medication Development is a procedure of carrying another medication to the market once a lead compound has been distinguished by the procedure of medication disclosure. Medication Development process incorporates pre-clinical examination and clinical preliminaries. Sub-atomic Pharmaceutics and Organic Process Research is the one of the top diaries in Molecular Pharmaceutics Journals. Sub-atomic Pharmaceutics and Organic Process Research Journal devoted to delivering investigation, knowledge and information identifying with inquiries of significance in understanding the pharmaceutical consideration. Atomic Pharmaceutics and Organic Process Research journal.

High Impact List of Articles

Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
Approaches to the design of clinical trials for primary sclerosing cholangitis*** Design of clinical trials for primary sclerosing cholangitis Mohamad H Imam, Keith D Lindor, Jayant A Talwalkar
Clinical Trail Methodology: Clinical Investigation
Research in acute decompensated heart failure: challenges and opportunities Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
Research in acute decompensated heart failure: challenges and opportunities Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
Research in acute decompensated heart failure: challenges and opportunities Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
Research in acute decompensated heart failure: challenges and opportunities Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
Research in acute decompensated heart failure: challenges and opportunities Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
Research in acute decompensated heart failure: challenges and opportunities Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
Research in acute decompensated heart failure: challenges and opportunities Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
Research in acute decompensated heart failure: challenges and opportunities Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials Sabina Antonela Antoniu
Review Article: Clinical Investigation
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials Sabina Antonela Antoniu
Review Article: Clinical Investigation
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials Sabina Antonela Antoniu
Review Article: Clinical Investigation
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials Sabina Antonela Antoniu
Review Article: Clinical Investigation
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials Sabina Antonela Antoniu
Review Article: Clinical Investigation
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials Sabina Antonela Antoniu
Review Article: Clinical Investigation
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials Sabina Antonela Antoniu
Review Article: Clinical Investigation
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials Sabina Antonela Antoniu
Review Article: Clinical Investigation

Clinical Investigation

Top Drug Development Journals

High Impact List of Articles

Relevant Topics in Clinical